
If you happen to be in NYC, my wife runs an awesome nonprofit funding nurse-led public health in Liberia and their annual fundraiser is in a couple weeks - come say hello! eventbrite.com/e/nursing-for…

CEO @Roivant, improving the delivery of healthcare to patients by treating every inefficiency as an opportunity

If you happen to be in NYC, my wife runs an awesome nonprofit funding nurse-led public health in Liberia and their annual fundraiser is in a couple weeks - come say hello! eventbrite.com/e/nursing-for…

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: @BridgeBioPharma Founder & CEO Neil Kumar and @Roivant CEO @gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode: biotechtv.com/post/off-targe…

This was a great conversation! Thanks @JMaraganore!
𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: @JMaraganore has been a champion of innovation throughout his career. He and @gline discuss the road to success at @Alnylam, today's environment, and keeping the U.S. on top. Watch the episode: biotechtv.com/post/off-targe…

Congrats @bradloncar!
Tomorrow is the two year anniversary of the launch of BiotechTV. That the industry’s top leaders recognize how it has grown in relevance and reach over this time is an awesome thing.

This was a fun one, @adamfeuerstein!
𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬 𝐰𝐢𝐭𝐡 𝐌𝐚𝐭𝐭 𝐆𝐥𝐢𝐧𝐞: @gline speaks with @statnews' @adamfeuerstein about the dynamics of biotech journalism and how it compares to other industries. Full video: biotechtv.com/post/off-targe…

This was a fun conversation! Thanks Behzad, @bradloncar and @BiotechTVHQ
𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: @gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector. Full video: biotechtv.com/post/behzad-ag…

𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: Tune in tomorrow for a new episode of Off-Target Effects with @gline. Matt interviews Avoro Capital's Behzad Aghazadeh.

Great chatting with you @MichelleF_Davis! Thanks for having us at #BIO24, @IAmBiotech!
Big Pharma's taking a breather on public M&A after a $50b deal streak at the end of last year. Overall biotech M&A is down but the value of deals involving private biotechs is up almost 200%, according to data compiled by Bloomberg. bloomberg.com/news/articles/…

No shame in coming behind Dave Ricks. @adamfeuerstein thanks for including us!
My "Best" list is here! The Best Biopharma CEO of 2023 is David Ricks $LLY Also honored: 👏Lars Fruergaard Jørgensen, $NVO 👏Reshma Kewalramani, $VRTX 👏Matt Gline, $ROIV 👏Tim Van Hauwermeiren, $ARGX Tomorrow, my WORST CEO list.... statnews.com/2023/12/18/best…

Thanks for having me over @AndrewE_Dunn! It was a lot of fun!
New: Check the latest entrant into Endpoints’ Slack room: Roivant CEO Matt Gline Hot off a $7.1B deal with Roche, we talked dealmaking, biotech markets, Vivek’s presidential run, Lehman Brothers days, and much more: endpts.com/the-endpoints-sla…

The Roivant team had an amazing day at @ENYFARMS for our annual NYC Roivant Day of Service! Thanks to all those who participated! #CommunityService #BuildingCommunity #Gardening #NYC

People like to talk about the importance of "vision," but ultimately running a startup is like doing science: you have to follow the truth wherever it leads. Vision is only valuable insofar as it predicts where you'll find truth.

“We’re incredibly honored to receive this recognition. Roivant has always prided itself not only on our innovative business model but also on our commitment to fostering a culture that challenges convention and drives transformative change in the #biopharma industry,”@gline
Fast Company's fifth annual Best Workplaces for Innovators list, created in collaboration with @Accenture, recognizes companies that understand vitally important breakthroughs can occur on the loading dock, not just in a corner office. Likewise, no single company has a monopoly on innovation: Five of the top 10 companies on this year's list are based outside of the U.S., including design democratizer Canva and engineering powerhouse Siemens, the only company to have appeared on Best Workplaces for Innovators all five years. See all the best workplaces here: bit.ly/3BwJvF2 #FCBestWorkplaces

Read why our CEO @gline says: "I came to realize that at least some people – and I put myself in this category – really thrive when our back is to the wall and there’s no way out but through.” #leadership #biotech #partnership #pharma invivo.pharmaintelligence.in…

"Many of our best people at Roivant are deeply, innately curious, and I think it’s important to nurture that curiosity – about the science, about the business, about why things are the way they are and whether there’s a better way.” @gline #biotech #leader https://t.co/qPLnbRvr0J

We are excited to announce a new ADAR1 focused drug discovery collaboration with leading pharma company Boehringer Ingelheim. @Boehringer @Roivant globenewswire.com/news-relea…